Role of acquired and inherited Prothrombotic Risk Factors in Pediatric Cerebral Venous Thrombosis — Preliminary Results of a Multicenter Case-Control Study

  • A. Kosch
  • U. Schulze-Horsel
  • C. Heller
  • R. Schobess
  • K. Kurnik
  • R. Sträter
  • U. Nowak-Göttl
Conference paper

Abstract

Venous thrombosis is an important cause of morbidity and mortality in adult and pediatric patients, and cerebral venous thrombosis is a serious but relatively uncommon diagnosis in children (1, 3, 4, 15–17, 19). It has been associated with underlying systemic conditions, such as dehydration, sepsis, systemic lupus erythematosus, homocystinuria, Behçet disease, acute lymphoblastic leukemia and vascular trauma (8). In addition, various genetic defects of proteins regulating blood coagulation have been discussed as risk factors for cerebral venous thrombosis in childhood (1, 10).

Keywords

Lymphoma EDTA Leukemia Citrate Dehydration 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barron TF, Gusnard DA, Zimmerman RA, Clancy RR (1992) Cerebral venous thrombosis in neonates and children. Pediatr Neurol 8: 112–116PubMedCrossRefGoogle Scholar
  2. 2.
    Cocharan FB, Packman S (1992) Homocystinuria presenting as sagittal sinus thrombosis. Eur Neurol 33: 1–3CrossRefGoogle Scholar
  3. 3.
    Ehrenforth S, von Depka Prondsinski M, Aygören-Pürsün E, Nowak-Göttl U, Scharrer I, Ganser A (1999) Study of the prothrombin gene 20210 GA variant in FV:Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolism. Arteriosclerosis Thrombosis and Vascular Biology 19: 276–80CrossRefGoogle Scholar
  4. 4.
    Egesel T, Buyukasik Y, Dundar SV, Gurgey A, Kirazli S, Bayraktar Y (2000) The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis. Journal of Clinical Gastroenterology 30: 66–71PubMedCrossRefGoogle Scholar
  5. 5.
    Gebara BM, Goetting FMG, Wang AM (1995) Dural sinus thrombosis complicating subclavian vein catheterization: treatment with local thrombolysis. Pediatrics 95: 138–140PubMedGoogle Scholar
  6. 6.
    Koster T, Rosendaal FR, de Ronde H, Briet E,Vandenbroucke JP, Bertina RM (1993). Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342: 1503–1506Google Scholar
  7. 7.
    Lee WT, Wang PJ, Young C, Shen YZ (1995) Cerebral venous thrombosis in children. Acta Paed Sin 36: 425–30Google Scholar
  8. 8.
    Lockman LA, Mastri A, Priest JR, Nesbit M (1980) Dural venous thrombosis in acute lymphoblastic leukemia. Pediatrics 66: 943–947PubMedGoogle Scholar
  9. 9.
    Medlock MD, Olivero WC, Hanigan WC, Wright RM, Winek SJ (1992) Children with cerebral venous thrombosis diagnosed with magnetic resonance imaging and magnetic resonance angiography. Neurosurgery 31: 870–876PubMedCrossRefGoogle Scholar
  10. 10.
    Nowak-Göttl U, Aschka I, Koch HG, Boos J, Dockhorn-Dworniczak B, Deufel T, Jürgens H, Kohlhase B, Kuhn N, Laupert A, Rath B, Wolff JEA, Schneppenheim R (1995) Resistance to activated protein C ( APCR) in children with acute lymphoblastic leukaemia-the need for a prospective multicentre study. Blood Coagulation & Fibrinolysis 6: 761–764CrossRefGoogle Scholar
  11. 11.
    Nowak-Göttl U, Junker R, Hartmeier M, Koch HG, Münchow N, Assmann G, von Eckardstein A (1999) Increased lipoprotein (a) is an important risk factor for venous thrombosis in childhood. Circulation 100: 743–748PubMedGoogle Scholar
  12. 12.
    Nowak-Göttl U, Sträter R, Heinecke A, Junker R, Koch HG, Schuierer G, von Eckardstein A. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischaemic stroke in childhood. Blood 1999; 94: 3678–3682PubMedGoogle Scholar
  13. 13.
    Poort SR, Rosendaal F, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma pro-thrombin levels and an increase in venous thrombosis. Blood 88: 3698–3703PubMedGoogle Scholar
  14. 14.
    Rees CD (1996) The population genetics of factor V Leiden (arg 506 Gln) Br J Haematol 95: 579–586PubMedCrossRefGoogle Scholar
  15. 15.
    Seixas CA, Hessel G, Ribeiro CC, Arruda VR, Annichino-Bizzacchi JM (1997) Factor V Leiden is not common in children with portal vein thrombosis. Thrombosis and Haemostasis 77: 258–261PubMedGoogle Scholar
  16. 16.
    Sifontes MT, Nuss R, Jacobson LJ, Griffin JH, Manco-Johnson MJ (1996). Thrombosis in otherwise well children with the factor V Leiden mutation. J Pediatr 128: 324–328PubMedCrossRefGoogle Scholar
  17. 17.
    Uttenreuther-Fischer MM, Vetter B, Hellmann C, Otting U, Ziemer S, Hausdorf G, Gaedicke G (1997) Paediatric thrombo-embolism: the influence of non-genetic factors and the role of activated protein C resistance and protein C deficiency. European Journal of Pediatrics 156: 227–281CrossRefGoogle Scholar
  18. 18.
    Uziel Y, Laxer RM, Blaser S, Andrew M, Schneider R, Silverman ED (1995) Cerebral vein thrombosis in childhood systemic lupus erythematosus. J Pediatr 126: 722–727PubMedCrossRefGoogle Scholar
  19. 19.
    Zuber M, Toulon P, Marnet L, Mas JL (1996) Factor V Leiden mutation in cerebral venous thrombosis. Stroke 27: 1721–1723PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • A. Kosch
  • U. Schulze-Horsel
  • C. Heller
  • R. Schobess
  • K. Kurnik
  • R. Sträter
  • U. Nowak-Göttl

There are no affiliations available

Personalised recommendations